ASSOCIATION OF DYSLIPIDEMIA WITH ANXIETY AND DEPRESSION IN PATIENTS OF POLYCYSTIC OVARIAN SYNDROME
Open Access
- 30 June 2021
- journal article
- research article
- Published by Khyber Medical University in Khyber Medical University Journal
- Vol. 13 (2), 113-7
- https://doi.org/10.35845/kmuj.2021.21298
Abstract
OBJECTIVE: To find-out the association of dyslipidemia with anxiety and depression in patients with polycystic ovarian syndrome (PCOS). METHODS: This descriptive cross-sectional study was conducted at Mardan Medical Complex, Mardan, Pakistan from December-2019 to March-2020. One hundred & forty diagnosed cases of PCOS, ranging in age from 20-40 years, were selected through purposive sampling. Anxiety and depression were calculated using hospital anxiety and depression scale (HADS) score. Total cholesterol (TC), triglycerides, low-density-lipoproteins (LDL), high-density-lipoproteins (HDL) and testosterone were tested through fasting blood samples. RESULTS: Anxiety and depression were documented in 102 (72.9%) & 99 (70.7%) cases respectively. Primary infertility, oligomenorrhoea, Hirsutism & acne were present in 69 (49.3%), 111 (73.5%), 81 (57.9%) and 55 (39.3%) patients respectively. Twenty-two (15.7%) patients were overweight/obese. All patients had raised testosterone levels and polycystic ovaries on ultrasound. Raised triglyceride levels (≥150 mg/dl), Low levels of HDL (≤ 60mg/dl), raised levels of LDL (≥130 mg/dl), raised cholesterol levels (≥200 mg/dl) were reported in 71/99 (71.7%), 56/99 (56.6%), 38/99 (38.4%) & 10/99 (10.2%) cases with depression as compared to 27/41 (65.9%), 13/41 (31.7%), 21/41 (51.2%) & 14/41(34.1%) non-depressed patients respectively. Similarly raised triglyceride levels, low levels of HDL, raised levels of LDL, raised cholesterol levels were reported in 73/102 (71.6%), 58/102 (56.9%), 40/102 (39.2%) & 12/102 (11.76%) cases with anxiety as compared to 25/38 (65.8%), 11/38 (28.9%), 19/38 (50%) and 12/38 (31.6%) patients without anxiety respectively. CONCLUSION: Dyslipidemia, anxiety and depression are very common in PCOS. Dyslipidemia is associated with anxiety and depression in PCOS patients.Keywords
This publication has 11 references indexed in Scilit:
- Relationship of Polycystic Ovarian Syndrome with Cardiovascular Risk FactorsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018
- Psychological burden among women with polycystic ovarian syndrome in Oman: a case–control studyInternational Journal of Women's Health, 2017
- Association between severity of depression and clinico-biochemical markers of polycystic ovary syndromeElectronic Physiciane, 2017
- Complications and challenges associated with polycystic ovary syndrome: current perspectivesInternational Journal of Women's Health, 2015
- A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employeesBMC Psychiatry, 2014
- Validation of the Friedewald Formula in Patients with Metabolic SyndromeCholesterol, 2014
- Depression, anxiety and cardiometabolic risk in polycystic ovary syndromeHuman Reproduction, 2011
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) SocietyJournal of Clinical Endocrinology & Metabolism, 2010
- Appropriate BMI levels for PCOS patients in Southern ChinaHuman Reproduction, 2010
- Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are PrematureJournal of Clinical Endocrinology & Metabolism, 2006